Skip to content

Clinical comparative efficacy and safety of Polyherbal Unani formulations.

A Clinical Study to Evaluate the Efficacy and Safety of Polyherbal Unani formulations in the management of IltihÄ?b TajÄ?wÄ«f- al-Anf Muzmin (Chronic Rhinosinusitis)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050913
Enrollment
40
Registered
2023-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J39- Other diseases of upper respiratory tract

Interventions

Intervention1: polyherbal Unani joshanda ( decoction) 20ml twice a day (Oral) for 28days InkibÄ?b (Steam Inhalation) (local) for 28days: polyherbal Unani joshanda ( decoction) of Asl-al-SÅ«s (Glycyrrh

Sponsors

State Unani Medical College, himmatganj Prayagraj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The following patients will be included 1 More than twelve weeks of persistent symptoms of rhinosinusitis 2 X ray PNS Waters view shows haziness or opacity and may show free fluid level in affected sinus 3 Those are signed on the consent paper and ready to follow protocol 4 Patient age within the range of 18 to 60 years 5 Both the gender Male & Female

Exclusion criteria

Exclusion criteria: The following patients will be excluded: 1 Patientâ??s age below 18 years and above 60 years 2 Pregnant and Lactating women 3 Nasal polyp, deviated nasal septum, mucocele, cyst, antrochoanal polyp, facial trauma 4 Significant Pulmonary/ Cardiovascular/ Hepato-renal dysfunctions 5 Known cases of immunocompromised states (HIV, AIDS etc.) 6 Patients not willing to attend treatment schedule regularly

Design outcomes

Primary

MeasureTime frame
the response to treatment will be assessed using the following parameters X-ray PNS CSAS (chronic sinusitis assessment score)Timepoint: Clinical assessment will be done at 0,1,2,3,4 weeks

Secondary

MeasureTime frame
CSAS (chronic sinusitis assessment scoreTimepoint: 10th,20th dat

Countries

India

Contacts

Public ContactDr Usamah Ahmad

State Unani medical College Prayagraj

asifhussainusmani@gmail.com7905831926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026